ABC-DLBCL cells with BCL10 mutants upregulated MALT1 activity as demonstrated by increased cleavage of substrates A20 and CYLD, and these cells retained sensitivity to both MI-2 and safimaltib (Supplemental Fig. 5A, B). The gene discussed is TNFAIP3; the disease is aneurysmal bone cyst.